18-31074805-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_024422.6(DSC2):āc.1766T>Cā(p.Met589Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,614,102 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.1766T>C | p.Met589Thr | missense_variant | 12/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.1766T>C | p.Met589Thr | missense_variant | 12/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.1337T>C | p.Met446Thr | missense_variant | 12/16 | NP_001393435.1 | ||
DSC2 | NM_001406507.1 | c.1337T>C | p.Met446Thr | missense_variant | 12/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.1766T>C | p.Met589Thr | missense_variant | 12/16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081.8 | c.1766T>C | p.Met589Thr | missense_variant | 12/17 | 1 | ENSP00000251081.6 | |||
DSC2 | ENST00000648081.1 | c.1337T>C | p.Met446Thr | missense_variant | 13/17 | ENSP00000497441.1 | ||||
DSC2 | ENST00000682357.1 | c.1337T>C | p.Met446Thr | missense_variant | 12/16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251062Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135700
GnomAD4 exome AF: 0.000186 AC: 272AN: 1461806Hom.: 1 Cov.: 32 AF XY: 0.000175 AC XY: 127AN XY: 727202
GnomAD4 genome AF: 0.000164 AC: 25AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74470
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 11 Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Phosphorus, Inc. | Aug 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jan 28, 2022 | The c.1766T>C p.(Met589Thr) missense variant identified in the DSC2 gene has 0.0001643 allele frequency in the gnomAD(v3) database (25 out of 152178 heterozygous alleles, no homozygotes) suggesting it is not a common benign variant in the populations represented in that database. The variant affects a conserved residue and is predicted benign by multiple in silico prediction tools (CADD score = 18.05, REVEL score = 0.064). This variant has been eported in the ClinVar database as a variant of uncertain significance [Variation ID: 410648] ) and has been reported in one affected individual in the literature with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257). Based on the available evidence, the c.1766T>C p.(Met589Thr) variant identified in the DSC2 gene is reported as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 589 of the DSC2 protein (p.Met589Thr). This variant is present in population databases (rs201856473, gnomAD 0.01%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257). ClinVar contains an entry for this variant (Variation ID: 410648). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DSC2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 22, 2021 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 20, 2022 | This missense variant replaces methionine with threonine at codon 589 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257). This variant has been identified in 20/282460 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2024 | Reported in published literature in a patient referred for arrhythmogenic right ventricular cardiomyopathy (ARVC) genetic testing and in patients with monomorphic/polymorphic ventricular tachycardia or sudden unexplained death who harbored additional cardiogenetic variants (PMID: 27532257, 35474678, 37589201); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31402444, 35474678, 27532257, 37589201) - |
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Sep 27, 2024 | This missense variant replaces methionine with threonine at codon 589 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257). This variant has been identified in 20/282460 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 19, 2024 | Variant summary: DSC2 c.1766T>C (p.Met589Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00018 in 1614102 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 7.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSC2 causing Cardiomyopathy phenotype (2.5e-05). c.1766T>C has been reported in the literature in individuals affected with Cardiomyopathy or sudden cardiac death but these reports lack detailed clinical phenotype description and segregation data (Walsh_2017, Ye_2019, Kotta_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 37589201, 27532257, 31402444). ClinVar contains an entry for this variant (Variation ID: 410648). Based on the evidence outlined above, the variant was classified as likely benign. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at